Cellvie Company
cellvie is pioneering Therapeutic Mitochondria Transfer, a novel treatment approach aimed at the cellular energy metabolism. The technology's first application will be in ischemia-reperfusion injury, specifically in kidney transplantation. But the aim is to develop a broad platform.
Headquarters:
Matzingen / Switzerland
Founded Date:
2018
Last Funding Type:
Seed
Investors Number:
1
Last Funding Date:
2021
Employee Number:
1-10
Total Funding:
5000000
Industry:
PharmTech
Investor Type:
Seed